Barry Buckland, Director at Enumeral Biomedical, holds 0.00 shares in Dyadic International (Ticker: DYAI), holds 244.17K shares in Enumeral Biomedical (Ticker: ENUMQ). Most recently, Barry Buckland Sold ― shares of Dyadic International on Dec 05, 2019 for an estimated value of 92.70K.

See the Hottest Stocks Based on Insider Trading >

Barry Buckland
Enumeral Biomedical (ENUMQ)
Director

Ranked #49,723 out of 78,624 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

-15.20%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

Barry Buckland does not currently own shares as a corporate insider.

A breakdown of Barry Buckland's holdings

See the Top Stocks by Insiders

Insider Roles

Dyadic International
(DYAI)

Director

Roles that Barry Buckland holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Dyadic International
(DYAI)

Rating:Informative Sell

Date:Dec 05, 2019 - Dec 05, 2020

Return:+2.80%

The most profitable trade made by Barry Buckland

See the Latest Stocks Traded by Insiders

Barry Buckland's Trading History

ENUMQ

Enumeral Biomedical

Dec 13, 2016

―

Informative Buy

26.00K

$244.17

DYAI

Dyadic International

Dec 05, 2019

Director

Informative Sell

92.70K

$0.00

List of latest transactions for each holding click on a transaction to see Barry Buckland's performance on stock

See All Insider Trading from Today

Barry Buckland insider profile FAQ

What is the percentage of profitable transactions made by Barry Buckland?

The percentage of profitable transactions made by Barry Buckland is 50%.

What is the average return per transaction made by Barry Buckland?

The average return per transaction made by Barry Buckland is -15.20%.

What stocks does Barry Buckland hold?

Barry Buckland holds: ENUMQ, DYAI stocks.

What was Barry Buckland’s latest transaction?

Barry Buckland latest transaction was an Informative Sell of $92.70K.

What was Barry Buckland's most profitable transaction?

Barry Buckland’s most profitable transaction was an Informative Sell of DYAI stock on December 5, 2019. The return on the trade was 2.80%.

What is Barry Buckland's role in Enumeral Biomedical?

Barry Buckland's role in Enumeral Biomedical is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Barry Buckland Insider Profile

Barry Buckland Enumeral Biomedical (ENUMQ)Director